文献速递中毒与环境急症呼吸衰竭与机械通气

二甲双胍通过激活AMP活化蛋白激酶通路对百草枯所致肺纤维化的保护作用

[Protective effect of metformin on pulmonary fibrosis caused by paraquat through activating AMP-activated protein kinase pathway].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2023-01-01
一句话结论小鼠实验中二甲双胍200 mg/kg灌胃21天可改善百草枯中毒小鼠21天生存率(70% vs 20%)并减轻肺纤维化,机制可能涉及激活AMPK、抑制TGF-β1/Smad3通路。

该研究将雄性C57BL/6J小鼠随机分为对照组、百草枯中毒模型组(PQ组)、二甲双胍干预组(PQ+MET组)、AMPK激动剂组(PQ+AICAR组)和AMPK抑制剂组(PQ+MET+CC组),以一次性腹腔注射1 mL百草枯溶液(20 mg/kg)建立中毒模型,造模2小时后给药,每日1次连续21天。结果显示,与PQ组相比,PQ+MET组和PQ+AICAR组21天生存率显著提高(70%、60% vs 20%,均P<0.05),肺纤维化程度和Ashcroft评分显著降低(1.50±0.55、2.00±0.63 vs 6.67±0.52,均P<0.05),羟脯氨酸、丙二醛含量及α-SMA、TGF-β1、p-Smad3蛋白表达显著降低,SOD活性及E-cadherin、p-AMPK蛋白表达显著升高(均P<0.05)。加入AMPK抑制剂CC后,二甲双胍的这些保护作用被抑制。结论认为二甲双胍可有效减轻百草枯中毒小鼠肺纤维化程度,其机制可能与激活AMPK、抑制TGF-β1/Smad3信号通路有关。

要点

  • 百草枯中毒小鼠模型中,二甲双胍200 mg/kg灌胃每日1次连续21天,21天生存率70% vs 模型组20%(P<0.05)。
  • AMPK激动剂AICAR 200 mg/kg腹腔注射组21天生存率60% vs 模型组20%(P<0.05),与二甲双胍组趋势一致。
  • 二甲双胍组Ashcroft评分1.50±0.55 vs 模型组6.67±0.52(P<0.05),肺纤维化程度显著减轻。
  • 二甲双胍降低肺组织羟脯氨酸(2.03±0.11 mg/L vs 4.92±0.65 mg/L)、MDA(2.06±1.48 kU/g vs 4.06±1.33 kU/g)及α-SMA、TGF-β1、p-Smad3表达(均P<0.05)。
  • 加入AMPK抑制剂CC后,二甲双胍的保护作用被抑制,提示其作用依赖AMPK激活。

适用人群与场景

  • 雄性C57BL/6J小鼠,通过一次性腹腔注射1 mL百草枯溶液(20 mg/kg)建立百草枯中毒模型;对照组注射等体积生理盐水。

处置流程与药物剂量

  • 造模2小时后,PQ+MET组给予2 mL 200 mg/kg二甲双胍溶液灌胃,每日1次连续21天。
  • PQ+AICAR组给予2 mL 200 mg/kg AICAR溶液腹腔注射,每日1次连续21天。
  • PQ+MET+CC组给予2 mL 200 mg/kg二甲双胍溶液灌胃后,再腹腔注射1 mL复合物C(CC)溶液(20 mg/kg),每日1次连续21天。
  • 对照组和PQ组给予2 mL生理盐水灌胃,每日1次连续21天。

研究设计与关键结果

  • 研究类型:动物实验;样本量:每组10只用于计算21天生存率,其余小鼠于造模后21天采集肺组织。
  • 与对照组相比,PQ组21天生存率显著降低,肺纤维化和Ashcroft评分显著增加,肺组织羟脯氨酸、MDA含量及α-SMA、TGF-β1、p-Smad3蛋白表达显著升高,SOD活性及E-cadherin、p-AMPK蛋白表达显著降低。
  • 与PQ组相比,PQ+MET组和PQ+AICAR组21天生存率显著提高(70%、60% vs 20%,均P<0.05)。
  • 与PQ组相比,PQ+MET组和PQ+AICAR组肺纤维化程度和Ashcroft评分显著降低(1.50±0.55、2.00±0.63 vs 6.67±0.52,均P<0.05)。
  • 与PQ组相比,PQ+MET组和PQ+AICAR组肺组织羟脯氨酸(mg/L:2.03±0.11、3.00±0.85 vs 4.92±0.65)、MDA(kU/g:2.06±1.48、2.10±1.80 vs 4.06±1.33)、α-SMA/GAPDH(0.23±0.06、0.16±0.06 vs 1.00±0.09)、TGF-β1/GAPDH(0.28±0.03、0.53±0.05 vs 0.92±0.06)、p-Smad3/GAPDH(0.52±0.04、0.69±0.06 vs 1.11±0.10)显著降低(均P<0.05)。
  • 与PQ组相比,PQ+MET组和PQ+AICAR组SOD活性(μmol/g:39.76±1.35、33.03±1.28 vs 20.08±1.79)、E-cadherin/GAPDH(0.91±0.08、0.72±0.08 vs 0.26±0.04)、p-AMPK/GAPDH(0.62±0.04、0.60±0.01 vs 0.20±0.04)显著升高(均P<0.05)。
  • 加入AMPK抑制剂CC溶液后,二甲双胍的上述保护作用被抑制。

证据类型、等级与局限

  • 证据类型:动物实验(小鼠模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文结论认为二甲双胍可有效减轻百草枯中毒小鼠的肺纤维化程度,其机制可能与激活AMPK、抑制TGF-β1/Smad3信号通路有关,且该作用可被AMPK抑制剂CC抑制。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To observe whether metformin (MET) inhibits transforming growth factor-β1 (TGF-β1)/Smad3 signaling pathway by activating adenosine activated protein kinase (AMPK), so as to alleviate the pulmonary fibrosis caused by paraquat (PQ) poisoning in mice.

METHODS: Male C57BL/6J mice were randomly divided into the Control group, PQ poisoning model group (PQ group), MET intervention group (PQ+MET group), AMPK agonist group (PQ+AICAR group), and AMPK inhibitor group (PQ+MET+CC group), according to a random number table method. A mouse model of PQ poisoning was established by one-time peritoneal injection of 1 mL PQ solution (20 mg/kg). The Control group was injected with the same volume of normal saline. After 2 hours of modeling, the PQ+MET group was given 2 mL of 200 mg/kg MET solution by gavage, the PQ+AICAR group was given 2 mL of 200 mg/kg AICAR solution by intraperitoneal injection, the PQ+MET+CC group was given 2 mL of 200 mg/kg MET solution by gavage and then 1 mL complex C (CC) solution (20 mg/kg) was intraperitoneally injected, the Control group and PQ group were given 2 mL of normal saline by gavage. The intervention was given once a day for 21 consecutive days. The 21-day survival rate of ten mice in each group was calculated, and the lung tissues of remaining mice were collected at 21 days after modeling. The pathological changes of lung tissues were observed under light microscope after hematoxylin-eosin (HE) staining and Masson staining, and the degree of pulmonary fibrosis was evaluated by Ashcroft score. The content of hydroxyproline in lung tissue and oxidative stress indicators such as malondialdehyde (MDA) and superoxide dismutase (SOD) were detected. The protein expressions of E-cadherin, α-smooth muscle actin (α-SMA), phosphorylated AMPK (p-AMPK), TGF-β1 and phosphorylated Smad3 (p-Smad3) in lung tissue were detected by Western blotting.

RESULTS: Compared with the Control group, the 21 days survival rate was significantly reduced, lung fibrosis and Ashcroft score were significantly increased in PQ group. In addition, the content of hydroxyproline, MDA and the protein expressions of α-SMA, TGF-β1 and p-Smad3 in lung tissue were significantly increased, while the activity of SOD and the protein expressions of E-cadherin and p-AMPK were significantly decreased in PQ group. Compared with the PQ group, the 21 days survival rates of mice were significantly improved in the PQ+MET group and PQ+AICAR group (70%, 60% vs. 20%, both P < 0.05). The degree of pulmonary fibrosis and the Ashcroft score were significantly reduced (1.50±0.55, 2.00±0.63 vs. 6.67±0.52, both P < 0.05). The content of hydroxyproline and MDA in lung tissue, as well as α-SMA, TGF-β1 and p-Smad3 protein expressions were significantly reduced [hydroxyproline (mg/L): 2.03±0.11, 3.00±0.85 vs. 4.92±0.65, MDA (kU/g): 2.06±1.48, 2.10±1.80 vs. 4.06±1.33, α-SMA/GAPDH: 0.23±0.06, 0.16±0.06 vs. 1.00±0.09, TGF-β1/GAPDH: 0.28±0.03, 0.53±0.05 vs. 0.92±0.06 p-Smad3/GAPDH: 0.52±0.04, 0.69±0.06 vs. 1.11±0.10, all P < 0.05], SOD activity and the protein expressions of E-cadherin and p-AMPK were significantly increased [SOD (μmol/g): 39.76±1.35, 33.03±1.28 vs. 20.08±1.79, E-cadherin/GAPDH: 0.91±0.08, 0.72±0.08 vs. 0.26±0.04, p-AMPK/GAPDH: 0.62±0.04, 0.60±0.01 vs. 0.20±0.04, all P < 0.05]. However, these protective effects of MET were inhibited by the addition of AMPK inhibitor CC solution.

CONCLUSIONS: MET can effectively alleviate the degree of pulmonary fibrosis in mice poisoned with PQ, and its mechanism may be related to the activation of AMPK and inhibition of TGF-β1/Smad3 signaling pathway, which can be inhibited by AMPK inhibitor CC.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Liu T, Gao L, Wang J, et al. [Protective effect of metformin on pulmonary fibrosis caused by paraquat through activating AMP-activated protein kinase pathway]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 38149395. doi:10.3760/cma.j.cn121430-20230407-00250

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。